Viewing insider transactions for Cyclerion Therapeutics, Inc.’s (NASDAQ:CYCN ) during the last yr, we see that insiders have been internet patrons. Which means that a bigger variety of shares have been bought by insiders in relation to shares bought.
Whereas insider transactions usually are not crucial factor on the subject of long-term investing, logic dictates it is best to pay some consideration as to if insiders are shopping for or promoting shares.
The Final 12 Months Of Insider Transactions At Cyclerion Therapeutics
The CEO, Interim CFO Peter Hecht made the largest insider